SomaLogic Announces New Collaboration with FDA to Advance Biosimilar Development
BOULDER, Colo., Oct. 29, 2020 (GLOBE NEWSWIRE) -- SomaLogic, Inc. announced today an agreement with the US Food and Drug Administration (FDA)’s Division of Applied Regulatory Science to evaluate the utility of large-scale analysis of proteins (proteomics) …